Skip to content

A Registry of Patients with Type B Aortic Syndromes

Type B aortic syndrome CLarifying the need for early Endovascular Aortic Repair (The B-CLEAR Registry)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12620000435987
Acronym
B-CLEAR
Enrollment
80
Registered
2020-04-02
Start date
2020-04-06
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This registry will include patients who present with an abnormality in the wall of their aorta (Type B aortic syndrome) with the aim of determining the natural history and clinical outcomes of this condition. Specifically, the group will look at the outcomes of patients who were treated with early intervention and/or basic medical therapy. From this study, the relationship between patient factors including kidney injury, and benefit from early intervention will be reported.

Interventions

Participants will be recruited from patients who present to Royal North Shore Hospital in Sydney, NSW, and are diagnosed with Type B Aortic Syndrome, whether complicated or uncomplicated. Informed consent will be obtained prior to registration. Data collection for the initial time point (baseline) will be for the duration of the initial hospital stay. This will record inpatient management. Following discharge, patients will be followed up at specific timepoints (1 week, 3 months, 6 months, 12 m

Participants will be recruited from patients who present to Royal North Shore Hospital in Sydney, NSW, and are diagnosed with Type B Aortic Syndrome, whether complicated or uncomplicated. Informed consent will be obtained prior to registration. Data collection for the initial time point (baseline) will be for the duration of the initial hospital stay. This will record inpatient management. Following discharge, patients will be followed up at specific timepoints (1 week, 3 months, 6 months, 12 months and annually thereafter) for the duration of the study (10 years). Patients will present for surveillance imaging prior to their appointment with their consultant vascular surgeon, or with a member of the research team. A quality-of-life questionnaire will also be completed at the same time. Follow up will take approximately 20 to 30 minutes. The registry also aims to include patients who presented from January 2019. After ensuring patient's survival status, written informed consent will be obtained. Follow up data will be collected from the consultant surgeon's private practice and surveillance scans from radiology labs.

Sponsors

Royal North Shore Hospital
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients over the age 18 presenting at Royal North Shore Hospital, Sydney, NSW, and diagnosed with a type B aortic dissection. They must have given written consent.

Exclusion criteria

Patients who do not wish to participate or give consent.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026